Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rentokil InitialRTO +0.26%85 Days Sales Outstanding is 61.27 as of Jun. 2026, which is 2% below its 10-year median of 62.55. GuruFocus rates RTO with a GF Score™ of 85/100 and a GF Value™ of $30.22 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,062 Business Services companies, Rentokil Initial ranks worse than 54.71% on this metric.
Rentokil Initial (NYSE:RTO) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Rentokil Initial Days Sales Outstanding Related Terms
Rentokil Initial Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Rentokil Initial's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RTO vs CTAS, CPRT, GPN: Days Sales Outstanding Comparison
For the Specialty Business Services subindustry, Rentokil Initial's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rentokil Initial Days Sales Outstanding vs Business Services Industry
For the Business Services industry and Industrials sector, Rentokil Initial's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Rentokil Initial's Days Sales Outstanding falls into.
Rentokil Initial Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rentokil Initial (RTO) has a Days Sales Outstanding of 61.27 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Rentokil Initial and its competitors. This is near median its historical median of 62.55. Over the past decade, Rentokil Initial's Days Sales Outstanding has ranged from 49.38 to 69.25. According to the industry distribution chart, Rentokil Initial ranks #581 out of 1062 companies in the Business Services industry, placing it in the top 54.7%.
Is Rentokil Initial's Days Sales Outstanding too high?
Rentokil Initial's current Days Sales Outstanding of 61.27 is near median its 10-year median of 62.55. Over the past 10 years, this metric has ranged from a low of 49.38 to a high of 69.25. The Business Services industry median Days Sales Outstanding is 56.82. Rentokil Initial's value of 61.27 is 7.8% above this industry median. Based on the distribution chart, Rentokil Initial ranks #581 out of 1062 companies in the Business Services industry, which is below the industry midpoint. Overall, Rentokil Initial has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rentokil Initial's Days Sales Outstanding compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Rentokil Initial ranks #581 out of 1062 companies for Days Sales Outstanding. This places Rentokil Initial in the lower half of its industry. The industry median Days Sales Outstanding is 56.82. Rentokil Initial's value of 61.27 is 7.8% above this benchmark. Historically, Rentokil Initial's own Days Sales Outstanding has ranged from 49.38 to 69.25 over the past decade. While the company's 10-year median is 62.55 vs. the industry median of 56.82, Rentokil Initial has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Business Services company?
The median Days Sales Outstanding among Business Services companies is 56.82, based on 1,062 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rentokil Initial's current Days Sales Outstanding of 61.27 is 7.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Rentokil Initial and its competitors. For the Business Services industry, the median Days Sales Outstanding is 56.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rentokil Initial's current Days Sales Outstanding is 61.27, which is near median its own 10-year median of 62.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rentokil Initial stock overvalued right now?
Based on GuruFocus' analysis, Rentokil Initial (RTO) is currently considered Modestly Undervalued. The stock's GF Value™ is $30.22, compared to a current price of $23.53 — trading 22.1% below its estimated fair value. The current Days Sales Outstanding is 61.27, which is near median its 10-year median of 62.55 and 7.8% above the Business Services industry median of 56.82. Rentokil Initial's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Rentokil Initial (RTO), the current Days Sales Outstanding is 61.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rentokil Initial (RTO) Overvalued in 2026?
Based on GuruFocus' analysis, Rentokil Initial stock appears to be undervalued.
The current stock price of $23.53 is trading 22.1% below its estimated GF Value™ of $30.22.
GuruFocus considers Rentokil Initial to be Modestly Undervalued.
Key valuation signals for RTO:
Days Sales Outstanding: 61.27 (near median its 10-year median of 62.55)
GF Value™: $30.22 vs. price of $23.53 (22.1% below fair value)
Industry Position: 7.8% above the Business Services median (#581 of 1062)
No single metric tells the full story. See the RTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
85GF Score
Get the complete analysis for RTO
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RTO has been successfully added to your 
